# DESCRIPTION

## TECHNICAL FIELD

- introduce technical field

## BACKGROUND ART

- describe tooth agenesis

## SUMMARY OF INVENTION

### Problem to be Solved by Invention

- state problem

### Solution for Problem

- introduce neutralizing antibody
- describe antibody's effect
- specify antibody's target
- describe antibody's structure
- specify antibody's sequence
- describe antibody's binding
- describe antibody's competition
- specify antibody's type
- describe pharmaceutical composition

### Effects of the Invention

- describe effects of invention

## MODE FOR CARRYING OUT THE INVENTION

- introduce USAG-1 and its functions
- motivate tooth agenesis treatment
- describe mouse model experiments
- summarize results of mouse model experiments
- produce antibodies against USAG-1
- describe functions of USAG-1
- define neutralizing activity of antibodies
- describe methods for determining neutralizing activity
- analyze obtained antibodies
- describe sequences of antibodies
- provide antibodies and mutants as invention
- define antibody A
- specify heavy chain complementarity determining regions
- specify light chain complementarity determining regions
- specify heavy chain variable region
- specify light chain variable region
- provide preferred antibody A
- provide more preferred antibody A
- provide still more preferred antibody A
- define antibody A with substitutions
- define antibody B
- specify heavy chain complementarity determining regions of antibody B
- specify light chain complementarity determining regions of antibody B
- define antibody B
- specify heavy chain complementarity determining regions
- specify light chain complementarity determining regions
- specify heavy chain variable region
- specify light chain variable region
- provide preferred antibody B
- provide more preferred antibody B
- provide still more preferred antibody B
- specify antibody B with substitutions
- provide preferred antibody B with substitutions
- define antibody C
- specify heavy chain complementarity determining regions of antibody C
- specify light chain complementarity determining regions of antibody C
- define antibody C
- specify heavy chain complementarity determining regions
- specify light chain complementarity determining regions
- specify heavy chain variable region
- specify light chain variable region
- specify combination of heavy and light chain variable regions
- specify substitutions in heavy and light chain variable regions
- specify combination of heavy and light chain complementarity determining regions
- specify substitutions in heavy and light chain complementarity determining regions
- specify combination of heavy and light chain variable regions with substitutions
- define antibody D
- specify heavy chain complementarity determining regions of antibody D
- specify light chain complementarity determining regions of antibody D
- define antibody D
- specify heavy chain complementarity determining regions
- specify light chain complementarity determining regions
- specify heavy chain variable region
- specify light chain variable region
- provide preferred antibody D
- provide more preferred antibody D
- provide still more preferred antibody D
- specify antibody D with substitutions
- provide preferred antibody D with substitutions
- define antibody E
- specify heavy chain complementarity determining regions of antibody E
- specify light chain complementarity determining regions of antibody E
- define antibody E
- specify heavy chain complementarity determining regions
- specify light chain complementarity determining regions
- describe heavy chain variable region
- describe light chain variable region
- specify sequence identity
- provide preferred embodiments
- describe substitution, deletion, insertion or addition
- define "several"
- explain conservative substitution
- provide examples of conservative substitution
- conclude antibody E or mutant thereof
- define sequence identity
- describe antibody or antigen-binding fragment
- motivate epitope binding
- describe competition for binding
- explain epitope binning
- describe binding affinity
- describe antibody types
- describe antigen-binding fragments
- describe isolated nucleic acid
- motivate pharmaceutical composition
- describe pharmaceutical composition
- describe administration routes
- describe treatment of tooth agenesis

### Example 1

- prepare antibody 1
- confirm Wnt inhibitory activity
- confirm BMP inhibitory activity
- select and classify neutralizing antibodies
- obtain 5 kinds of mouse anti-USAG-1 neutralizing antibodies

### Example 2

- confirm neutralizing activity of 5 mouse anti-USAG-1 neutralizing antibodies

### Example 3

- administer antibody A to congenital tooth agenesis model mice

### Example 4

- administer antibody B to congenital tooth agenesis model mice

### Example 5

- administer mixture of 5 antibodies to Wnt10a-deficient mice

### Example 6

- confirm recognition of human USAG-1 by 5 mouse anti-USAG-1 neutralizing antibodies

### Example 7

- prepare mouse USAG-1 neutralizing antibodies using rat USAG-1 protein
- select and classify neutralizing antibodies
- confirm recognition of human USAG-1 by 4 mouse anti-USAG-1 neutralizing antibodies

### Example 8

- perform epitope binning of 9 mouse USAG-1 neutralizing antibodies
- classify 9 antibodies into 4 groups based on epitopes

### Example 9

- epitope mapping of antibody E37
- prepare peptide library
- bind peptides to cellulose membrane
- add E37 antibody and incubate
- wash and add secondary antibody
- use ECL solution for color development
- identify epitope sequence
- summarize epitope mapping results
- introduce Example 10
- determine affinities of antibodies
- immobilize antibodies on biosensor
- add purified recombinant mouse USAG-1 protein
- calculate affinities by global fitting

## INDUSTRIAL APPLICABILITY

- application of antibody

